Analyst Ratings for OncoSec Medical (ONCS)

ONCS Rating Summary

  |   Expand Research on ONCS
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 6.7 / 10   Percentile Rank: 71%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/14/2022 BTIG Kaveri Pohlman Downgrade Neutral
(Buy)		 N/A
(N/A)		 4.14
(0.28)		 -93.24% Details
7/27/2020 Dawson James
» Updated 3/17/2022		 Jason Kolbert New Coverage Buy
(N/A)		 N/A
(N/A)		 3.19
(0.28)		 -91.22% Details